Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06654271 · ClinicalTrials.gov registry record · NA
Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT Using Integrated Intraprocedural Imaging
A NA study of Peripheral Pulmonary Lesion and Lung Nodule, Solitary, sponsored by Vanderbilt University Medical Center.
- Active
- Registry status
- NA
- Development phase
- 440
- Enrollment target
- 4
- Study locations
NCT06654271 is a NA study of Peripheral Pulmonary Lesion and Lung Nodule, Solitary that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 440 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT06654271, a NA study of Peripheral Pulmonary Lesion and Lung Nodule, Solitary, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 440 participants
- Enrollment target
- 4
- Study locations
Study Summary
RELIANT 2 is a pragmatic randomized controlled trial. The goal of this study is to compare the diagnostic yield of robotic assisted bronchoscopy with integrated cone beam computed tomography to that of electromagnetic navigation bronchoscopy with integrated digital tomosynthesis in patients undergoing bronchoscopy to biopsy a pulmonary lesion.
Conditions Studied
Interventions
- DEVICE Robotic assisted bronchoscopy (RAB)
- DEVICE Electromagnetic navigation bronchoscopy (ENB)
Study Locations (4)
Tennessee
- Vanderbilt University Medical Center - Nashville
- Vanderbilt University Medical Center - Nashville
Illinois
- Rush University Medical Center - Chicago
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 440 participants |
| Start Date | 2024-11-11 |
| Est. Completion | 2026-10-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06654271
The ClinicalTrials.gov registry entry for NCT06654271 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 440 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Peripheral Pulmonary Lesion appearing as the primary indexed condition, and to 2 interventions - of which Robotic assisted bronchoscopy (RAB) is the first listed.
NCT06654271 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Tennessee, Illinois, Maryland.
Frequently Asked Questions
What is clinical trial NCT06654271 about?
NCT06654271 is a clinical study titled "Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT Using Integrated Intraprocedural Imaging". RELIANT 2 is a pragmatic randomized controlled trial. The goal of this study is to compare the diagnostic yield of robotic assisted bronchoscopy with integrated cone beam computed tomography to that of electromagnetic navigation bronchoscopy with integrated digital tomosynthesis in patients undergoi...
What is the current status of trial NCT06654271?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 440 participants. The study started on 2024-11-11. Estimated completion is 2026-10-14.
What conditions does trial NCT06654271 study?
This clinical trial studies the following conditions: Peripheral Pulmonary Lesion, Lung Nodule, Solitary.
What interventions are being tested in trial NCT06654271?
The interventions under investigation include: Robotic assisted bronchoscopy (RAB) (DEVICE), Electromagnetic navigation bronchoscopy (ENB) (DEVICE).
Who is sponsoring clinical trial NCT06654271?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06654271 being conducted?
This trial has 4 study locations across Illinois, Maryland, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.